SFXN2 adjusts cell proliferation in multiple myeloma
收藏integrated proteome resources2026-02-07 收录
官方服务：
资源简介：
SFXN2 adjusts cell proliferation in multiple myeloma
应用场景：
创建时间：
2021-07-28
相关数据集
MS Analysis Reveals the Potential Signaling Pathway for RFWD2 Function in multiple myeloma
MS Analysis Reveals the Potential Signaling Pathway for RFWD2 Function in multiple myeloma
integrated proteome resources80
Different CAP parameter (output voltage and resistance value) effects for MSC growth in vitro.
Note: “+” means positive effects (i.e., non-inhibited or increased cell proliferation when compared to untreated group) for MSCs; “−” means negative inhibited effects (i.e., decreased cell proliferati
Figshare2015-12-02 更新40
bulk RNA-seq data analysis of primary human mesenchymal stem cells of Multiple Myeloma patients compared to control patients
Purpose: In this study we compared bone marrow-derived mesenchymal stem cells (MSC) of 6 Multiple Myeloma patients (MM-MSC) with MSC of 5 control donors with other (non) malignant diseases (CTR-MSC) t
NIAID Data Ecosystem20
Gene expression signatures for human interleukin-6 (IL-6) treatment in human multiple myeloma (MM) cell lines.. Gene expression signatures for human interleukin-6 (IL-6) treatment in human multiple myeloma (MM) cell lines.
To investigate the effect of IL-6 on gene expression in IL-6-dependent MM cell lines, we have employed whole genome microarray expression profiling as a discovery platform to identify genes with the p
NIAID Data Ecosystem60
Upregulated genes and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways.
Using the Goeman's global test method the degree of distinction between myeloma cell samples (MM) and normal bone marrow plasma cell (BMPC) samples was investigated. The significance of p-level indica
NIAID Data Ecosystem20
